ATE350046T1 - Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments - Google Patents

Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments

Info

Publication number
ATE350046T1
ATE350046T1 AT02014086T AT02014086T ATE350046T1 AT E350046 T1 ATE350046 T1 AT E350046T1 AT 02014086 T AT02014086 T AT 02014086T AT 02014086 T AT02014086 T AT 02014086T AT E350046 T1 ATE350046 T1 AT E350046T1
Authority
AT
Austria
Prior art keywords
blood
oxide concentration
medication
produce
nitrogen oxide
Prior art date
Application number
AT02014086T
Other languages
English (en)
Inventor
Anthony Ernest Bolton
Original Assignee
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Ireland Ltd filed Critical Vasogen Ireland Ltd
Application granted granted Critical
Publication of ATE350046T1 publication Critical patent/ATE350046T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
AT02014086T 1992-02-07 1993-02-08 Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments ATE350046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83279892A 1992-02-07 1992-02-07
US94132692A 1992-09-04 1992-09-04

Publications (1)

Publication Number Publication Date
ATE350046T1 true ATE350046T1 (de) 2007-01-15

Family

ID=27125561

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93904180T ATE219953T1 (de) 1992-02-07 1993-02-08 Verfahren zur erhöhung den stickoxidkonzentration im blut
AT02014086T ATE350046T1 (de) 1992-02-07 1993-02-08 Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93904180T ATE219953T1 (de) 1992-02-07 1993-02-08 Verfahren zur erhöhung den stickoxidkonzentration im blut

Country Status (13)

Country Link
US (1) US5834030A (de)
EP (2) EP1243278B1 (de)
JP (1) JP3989949B2 (de)
AT (2) ATE219953T1 (de)
AU (1) AU681999B2 (de)
CA (1) CA2129630C (de)
DE (2) DE69334101T2 (de)
DK (2) DK0680346T3 (de)
ES (2) ES2280454T3 (de)
HK (1) HK1053068B (de)
NZ (1) NZ249176A (de)
PT (2) PT1243278E (de)
WO (1) WO1993015779A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
AU760465B2 (en) * 1995-05-05 2003-05-15 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
ES2205026T3 (es) * 1995-05-05 2004-05-01 Vasogen Ireland Limited Efectos de revestimiento endotelial y tratamiento de trastornos vasospasmicos.
US6866755B2 (en) * 2001-08-01 2005-03-15 Battelle Memorial Institute Photolytic artificial lung
CA2206180A1 (en) * 1997-05-27 1998-11-27 Vasogen Inc. Treatment of chronic post-traumatic pain syndromes
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
PT1011696E (pt) * 1997-09-12 2004-03-31 Vasogen Ireland Ltd Tratamento do stresse e precondicoes contra o stresse
JPH11217330A (ja) 1998-01-30 1999-08-10 Sumitomo Pharmaceut Co Ltd 神経栄養因子分泌促進剤
US6264646B1 (en) 1998-11-13 2001-07-24 Vasogen Ireland Limited Method for preventing and reversing atherosclerosis in mammals
US7045124B1 (en) * 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
CA2360268A1 (en) * 1999-01-12 2000-07-20 Vasogen Ireland Limited Pre-conditioning against cell death
AU3877800A (en) * 1999-03-30 2000-10-16 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
DE60009724T2 (de) * 1999-09-16 2005-04-28 Vasogen Ireland Ltd., Shannon Vorrichtung zum beeinflussen des blutes eines säugetieres
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
CA2309424A1 (en) 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
AU8484901A (en) * 2000-08-11 2002-02-25 David R Whitlock Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
NL1015999C2 (nl) * 2000-08-23 2002-02-26 A J Van Liebergen Holding B V Inrichting voor het verwarmen van bloed of andere fysiologische vloeistoffen.
CA2327630A1 (en) * 2000-12-05 2002-06-05 Vasogen Ireland Limited Transforming growth factor regulation
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
DE60229108D1 (de) * 2001-01-16 2008-11-13 Univ Michigan Biokatalytische und biomimetische erzeugung von stickoxid in situ an substrat/blut-grenzflächen
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7122208B2 (en) * 2001-04-06 2006-10-17 Vasogen Ireland Limited Compositions containing apoptotic entities
CA2465487C (en) * 2001-08-01 2012-03-20 Bruce F. Monzyk Photolytic cell for providing physiological gas exchange
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
AU2003218583A1 (en) * 2002-04-10 2003-10-27 Vasogen Ireland Ltd Electrocardiographic aspects of chf treatment
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20050051497A1 (en) * 2003-07-31 2005-03-10 Latino Joseph S. Viral inactivation using ozone
EP1667646A4 (de) * 2003-09-26 2007-07-04 David R Whitlock Verfahren zur verwendung von ammoniak-oxidierenden bakterien
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
US20080029093A1 (en) 2004-05-11 2008-02-07 Alex Stenzler Intermittent Dosing Of Nitric Oxide Gas
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
EP1773360A4 (de) * 2004-07-20 2009-09-02 Vasogen Ireland Ltd Behandlung von akuten entzündlichen zuständen
CN100420490C (zh) * 2005-04-13 2008-09-24 刘余厚 全自动紫外线照射充氧自血回输处理方法及设备
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
EP1968664B1 (de) * 2005-12-02 2010-10-27 The Regents Of The University Of Michigan Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
US20080181832A1 (en) * 2007-01-30 2008-07-31 Lih-Ren Shiue Pocket-size ozone generator
CA2902061C (en) * 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
KR20230165365A (ko) 2014-04-15 2023-12-05 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
AU2015257334B2 (en) * 2014-05-09 2021-02-25 Thankstem S.R.L. Method for expanding adult stem cells from whole blood
SE541036C2 (en) 2014-09-15 2019-03-12 Sangair Ab Apparatus and system for ozonating blood, and method for ozonating blood prior to storage
WO2022119900A1 (en) * 2020-12-01 2022-06-09 Boston Scientific Scimed, Inc. Intravascular ultraviolet catheter and methods for making and using the same
EP4295872A1 (de) * 2022-06-22 2023-12-27 Purotech S.r.l. Vorrichtung zur behandlung von blut
IT202300002148A1 (it) * 2023-02-08 2024-08-08 Purotech S R L Apparato per il trattamento ematico.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695647A (en) * 1901-10-30 1902-03-18 James Harold Warner Combination-tile for floors.
DE1068428C2 (de) * 1957-05-21 1960-04-21 Hermann Dr Med Jentjens Verfahren und Einrichtung zur Herstellung von oxygeniertrm Blut
US3325641A (en) * 1964-02-17 1967-06-13 George W Jones Apparatus for treating a thin film of liquid by exposure to radiant energy
US3715430A (en) * 1969-08-04 1973-02-06 E Ryan Purified oxygen gas containing ozone and higher oxygen polymers
DE2926523A1 (de) * 1979-06-30 1981-01-22 Margit Stadtlaender Geraet zur therapeutischen behandlung von blut und anderen koerpereigenen wie auch koerperfremden fluessigkeiten, substanzen und gasen zum zweck der therapeutischen wie auch diagnostischen anwendung in der human- wie auch veterinaermedinzin usw.
JPS58198466A (ja) * 1982-05-12 1983-11-18 Teijin Ltd ５−チアプロスタグランジン類およびその製造法
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE8704467U1 (de) * 1987-01-15 1988-05-26 Quarzlampenfabrik Dr.-Ing. Felix W. Müller GmbH & Co KG, 45239 Essen Gerät zur Herstellung von oxygeniertem Blut
DE3881473T2 (de) * 1987-10-22 1993-09-09 Duthie Jun Robert E Verfahren und sterilisationsvorrichtung.
DE68921912D1 (de) * 1988-04-29 1995-05-04 Medizone Int Inc Vorrichtung für die gesteuerte Generierung und Verabreichung von Ozon.
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
WO1993015779A1 (en) 1993-08-19
CA2129630C (en) 2003-09-23
NZ249176A (en) 1996-11-26
DE69332087D1 (de) 2002-08-08
CA2129630A1 (en) 1993-08-08
EP0680346A1 (de) 1995-11-08
DE69332087T2 (de) 2002-10-24
EP1243278A3 (de) 2003-02-26
JP3989949B2 (ja) 2007-10-10
DE69334101D1 (de) 2007-02-15
JPH07503722A (ja) 1995-04-20
EP1243278A2 (de) 2002-09-25
PT680346E (pt) 2002-10-31
DK0680346T3 (da) 2002-10-28
DE69334101T2 (de) 2007-10-04
ES2179828T3 (es) 2003-02-01
ATE219953T1 (de) 2002-07-15
EP0680346B1 (de) 2002-07-03
EP1243278B1 (de) 2007-01-03
AU3506393A (en) 1993-09-03
US5834030A (en) 1998-11-10
HK1053068A1 (en) 2003-10-10
PT1243278E (pt) 2007-04-30
HK1053068B (en) 2007-03-30
AU681999B2 (en) 1997-09-18
DK1243278T3 (da) 2007-05-07
ES2280454T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
ATE350046T1 (de) Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments
DE10299002I1 (de) Verwendung von No zur Behandlung oder Praevention der Bronchokonstriktion
ATE88890T1 (de) D-cycloserin und d-alanin enthaltende mischung zur verbesserung des gedaechtnisses und des lernvermoegens oder zur behandlung von kognitiven und psychotischen erkrankungen.
ATE201594T1 (de) Verwendung von venlafaxin oder eines aryloxy- propanaminderivates zur herstellung eines medikaments zur behandlung von inkontinenz
DE69102695D1 (de) Behandlung von verunreinigten abwässern und bodenwässern.
DE122005000011I1 (de) Verwendung von Tomoxet in zur Behandlung von Hyperaktivit{t mit Aufmerksamkeitsstörungen.
ATE21046T1 (de) Verfahren zur absorption von schwefeldioxid.
SE8802781D0 (sv) Forfarande for avfuktning av gaser
SE9302478D0 (sv) Gasblandning och apparat foer att tillfoera gasblandningen till lungorna hos ett levande vaesen
DE3784188D1 (de) Verfahren zur behandlung von industriellen gasen, die schwefelverbindungen enthalten.
BR8904041A (pt) Processo para o tratamento de material organico
ATE50539T1 (de) Verfahren zum entkeimen von verpackungsbehaeltern und -materialien, insbesondere fuer eine verwendung im pharmazeutischen und kosmetischen bereich und anlage zur ausfuehrung des verfahrens.
ATA156089A (de) Verfahren zur herstellung von sauerstoff und/oder ozon
ATE106250T1 (de) Verwendung von antikörper-antigen-wechselwirkung zum schutz oder modulation der biologischen aktivität.
ATE148715T1 (de) Verfahren zur reinigung von komerziellen karraghenanen
ATE143804T1 (de) Zusammensetzung zur behandlung von mastitis und metritis
DK0398234T3 (da) Forbedret fremgangsmåde til fjernelse af cyanid fra spildevand
DE59207095D1 (de) Verfahren zur Herstellung von aktiviertem Protein C
NO962580D0 (no) Metallimplantat og fremgangsmåte for behandling av et metallimplantat
ATE56363T1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
ATE176175T1 (de) Verfahren zur behandlung von schwefeldioxid enthaltenden gasen
ATE151068T1 (de) Verfahren zur reinigung von ethalfluralin
DE3881984D1 (de) Verfahren zur reduktion von stickoxiden mit minimiertem anfall anderer schadstoffe.
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ATE142188T1 (de) Verfahren zur reinigung von 1,1-dichlor-1- fluorethan

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1243278

Country of ref document: EP

REN Ceased due to non-payment of the annual fee